• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • About
  • Our Products
    • Restoret
  • Team
EyeBio

EyeBio

  • Business Development
  • News
  • Contact

Back to Team

Frances Betts

Global Head, Clinical Operations

Frances joined EyeBio as Head of Clinical Operations in September 2022. In this role, Frances is responsible for clinical operations worldwide to ensure the successful delivery of clinical studies.

Frances has a 30-year career in clinical development. Prior to joining EyeBio, Frances worked in clinical research developing products in oncology, virology, and ophthalmology for a range of companies. Earlier in her career, Frances worked at Roche for over 10 years and participated in the successful filing of Roferon®, Neupogen®, and MabThera®. Following Roche, she subsequently joined Eyetech and was part of the team developing Macugen.

In recent years Frances has supported many studies to develop products in ophthalmology ranging from first in human Phase I studies to large global Phase III studies.

Footer

Contact Us

Please fill out the brief form below with any questions or inquiries, and a member of our team will connect with you soon.

Business Development

EyeBio is bringing disruptive innovation to the field of ophthalmology. We actively seek to expand our pipeline of promising investigational therapies, and we welcome inquiries regarding in-licensing and acquisition of assets into our portfolio.

To learn more, please contact Sarah Milsom, Chief Operating Officer of EyeBio, at s.milsom@nulleyebiotech.com.

Privacy Policy
Terms of Use
Cookie Policy
Accessibility Statement

EyeBio

LinkedIn

Copyright © 2022 EyeBio

logo
  • About
  • Our Products
    • Restoret
  • Team
  • Business Development
  • News
  • Contact